Results 181 to 190 of about 2,863,004 (297)

Psychometric properties of patient-reported outcome measures for periacetabular osteotomy [PDF]

, 2019
Clohisy, John C, Pascual-Garrido, Cecilia, Wasko, Marcin K, Yanik, Elizabeth L   +3 more
core   +1 more source

The Essence of Clinical Practice Guidelines for Lumbar Spinal Stenosis, 2021: 2. Diagnosis and Evaluation

Spine Surgery and Related Research, 2023
Miho Sekiguchi
doaj   +1 more source

Patient-Reported-Outcome-Measures (PROMs) After Gastrointestinal Endoscopic Resections. [PDF]

United European Gastroenterol J
Retzbach L, Fuchs KH, Brand M, Lux TJ, Meining A.   +4 more
europepmc   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Patient-reported Outcome Measures in Pediatric Orthopaedics. [PDF]

J Pediatr Soc North Am
Mohr M, McClure PK, Nowlan NC, Green CJ.
europepmc   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Patient-reported outcome measures in prostate research: a scoping review. [PDF]

BJU Int
Young GJ, Walsh EI, Lane JA, Donovan JL, Drake MJ, Pedder H, Metcalfe C.   +6 more
europepmc   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Comprehensive Conservative Care for Kidney Failure - the Need for Evidence-Based Guidance

Kidney International Reports
Olalekan Lee Aiyegbusi
doaj   +1 more source

Patient-Reported Outcome Measures in Fetal Medicine: A Pilot Feasibility Study. [PDF]

Prenat Diagn
Crombag NMTH, Teeuwen B, Akkerman EMP, Adriaanse BME, Depla AL, Franx A, Oerlemans AJM, Stemkens D, Henneman L, Bekker MN.   +9 more
europepmc   +1 more source